A Randomized, Double-Blind, Placebo-controlled, Three Arm, Parallel Group, Multi-Centric, Clinical Study to Evaluate the Therapeutic Bio-equivalence of Two Tacrolimus 0.03% Topical Ointment Formulations in Adult Patients with Moderate to Severe Atopic Dermatitis - NA

Trial Profile

A Randomized, Double-Blind, Placebo-controlled, Three Arm, Parallel Group, Multi-Centric, Clinical Study to Evaluate the Therapeutic Bio-equivalence of Two Tacrolimus 0.03% Topical Ointment Formulations in Adult Patients with Moderate to Severe Atopic Dermatitis - NA

Not yet recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Aug 2016

At a glance

  • Drugs Tacrolimus (Primary)
  • Indications Atopic dermatitis
  • Focus Pharmacokinetics
  • Sponsors Intas Pharmaceuticals
  • Most Recent Events

    • 25 Aug 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top